Evgeniy Nasonov (E L Nasonov)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 39

Top Topics

Rheumatoid Arthritis

Monoclonal Antibody

Disease Activity

Top Venues

Terapevticheskii arkhiv

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Y L Korsakova, Tatiana V Korotaeva, E I Loginova, E E Gubar, A V Petrov, I M Patrikeeva, I F Umnova, V N Sorotskaya, I N Pristavskii, M V Sedunova, Evgeniy Nasonov
[Clinical and instrumental characteristics of psoriatic arthritis in men and women. Data from a cohort observational study]. Terapevticheskii arkhiv 96 (5) (2024)
L V Kondratyeva, Tatiana V Popkova, Evgeniy Nasonov
[The effect of hypothyroidism on cardiovascular events and type 2 diabetes mellitus developing in rheumatoid arthritis]. Terapevticheskii arkhiv 96 (5) (2024)
Y L Korsakova, Tatiana V Korotaeva, E I Loginova, E E Gubar, A V Petrov, I M Patrikeeva, I F Umnova, V N Sorotskaya, I N Pristavskii, M V Sedunova, Evgeniy Nasonov
[Clinical and instrumental characteristics of psoriatic arthritis in men and women. Data from a cohort observational study]. Terapevticheskii arkhiv 96 (5) (2024)
Tatiana Reshetnyak, K S Nurbaeva, I V Ptashnik, A A Kudrieva, Alexey A Belogurov, Alexander M Lila, Evgeniy Nasonov
[NETosis in lupus nephritis]. Terapevticheskii arkhiv 96 (5) (2024)
Eugen Feist, Roy M Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin, Sofia Kuzkina, Michael Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S Smolen
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment. Annals of the rheumatic diseases (2024)
M S Eliseev, O V Zhelyabina, Evgeniy Nasonov
[Uric acid, cognitive disorders, neurodegeneration]. Terapevticheskii arkhiv 96 (5) (2024)
M S Eliseev, O V Zhelyabina, Evgeniy Nasonov
[Uric acid, cognitive disorders, neurodegeneration]. Terapevticheskii arkhiv 96 (5) (2024)
L V Kondratyeva, Tatiana V Popkova, Evgeniy Nasonov
[The effect of hypothyroidism on cardiovascular events and type 2 diabetes mellitus developing in rheumatoid arthritis]. Terapevticheskii arkhiv 96 (5) (2024)
Y L Korsakova, Tatiana V Korotaeva, E I Loginova, E E Gubar, A V Petrov, I M Patrikeeva, I F Umnova, V N Sorotskaya, I N Pristavskii, M V Sedunova, Evgeniy Nasonov
[Clinical and instrumental characteristics of psoriatic arthritis in men and women. Data from a cohort observational study]. Terapevticheskii arkhiv 96 (5) (2024)
Tatiana Reshetnyak, K S Nurbaeva, I V Ptashnik, A A Kudrieva, Alexey A Belogurov, Alexander M Lila, Evgeniy Nasonov
[NETosis in lupus nephritis]. Terapevticheskii arkhiv 96 (5) (2024)
Evgeniy Nasonov
[Autoimmunity in rheumatology: A review]. Terapevticheskii arkhiv 95 (12) (2023)
Evgeniy Nasonov
[Autoimmunity in rheumatology: A review]. Terapevticheskii arkhiv 95 (12) (2023)
T S Panevin, R V Rozhivanov, Evgeniy Nasonov
[Hypogonadism syndrome in men with inflammatory joint diseases: A review]. Terapevticheskii arkhiv 95 (5) (2023)
Tatiana Reshetnyak, T A Lisitsyna, Fariza Cheldieva, A A Shumilova, Svetlana I Glukhova, M N Starovoytova, N V Seredavkina, O V Desinova, Z G Verizhnikova, Evgeniy Nasonov
[Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients]. Terapevticheskii arkhiv 95 (5) (2023)
Y L Korsakova, Tatiana V Korotaeva, E I Loginova, E E Gubar, L D Vorobyeva, Svetlana I Glukhova, Evgeniy Nasonov
[A new integral enthesial-comorbididity index of psoriatic arthritis activity]. Terapevticheskii arkhiv 95 (5) (2023)
T S Panevin, R V Rozhivanov, Evgeniy Nasonov
[Hypogonadism syndrome in men with inflammatory joint diseases: A review]. Terapevticheskii arkhiv 95 (5) (2023)
Y L Korsakova, Tatiana V Korotaeva, E I Loginova, E E Gubar, L D Vorobyeva, Svetlana I Glukhova, Evgeniy Nasonov
[A new integral enthesial-comorbididity index of psoriatic arthritis activity]. Terapevticheskii arkhiv 95 (5) (2023)
Elena V Gerasimova, Tatiana V Popkova, M V Shalygina, Irina G Kirillova, Daria A Gerasimova, Svetlana I Glukhova, Evgeniy Nasonov
[Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk]. Terapevticheskii arkhiv 95 (5) (2023)
Evgeniy Nasonov, Tatiana Reshetnyak, S K Solovyev, Tatiana V Popkova
[Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future]. Terapevticheskii arkhiv 95 (5) (2023)
T S Panevin, R V Rozhivanov, Evgeniy Nasonov
[Hypogonadism syndrome in men with inflammatory joint diseases: A review]. Terapevticheskii arkhiv 95 (5) (2023)
Elena V Gerasimova, Tatiana V Popkova, M V Shalygina, Irina G Kirillova, Daria A Gerasimova, Svetlana I Glukhova, Evgeniy Nasonov
[Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk]. Terapevticheskii arkhiv 95 (5) (2023)
Evgeniy Nasonov, Tatiana Reshetnyak, S K Solovyev, Tatiana V Popkova
[Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future]. Terapevticheskii arkhiv 95 (5) (2023)
Tatiana Reshetnyak, T A Lisitsyna, Fariza Cheldieva, A A Shumilova, Svetlana I Glukhova, M N Starovoytova, N V Seredavkina, O V Desinova, Z G Verizhnikova, Evgeniy Nasonov
[Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients]. Terapevticheskii arkhiv 95 (5) (2023)
A A Abramkin, T A Lisitsyna, D Yu Veltishchev, O F Seravina, O B Kovalevskaya, Svetlana I Glukhova, Evgeniy Nasonov
[Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis]. Terapevticheskii arkhiv 94 (5) (2022)
Eugen Feist, Saeed Fatenejad, Sergey Grishin, Elena Korneva, Michael E Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S Smolen, Roy M Fleischmann
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study. Annals of the rheumatic diseases 81 (12) (2022)
Tatiana Reshetnyak, Fariza Cheldieva, M V Cherkasova, Alexander M Lila, Evgeniy Nasonov
[Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome]. Terapevticheskii arkhiv 94 (5) (2022)
Y L Korsakova, E I Loginova, Tatiana V Korotaeva, E E Gubar, Svetlana I Glukhova, E A Vasilenko, Evgeniy Nasonov
[The burden of progression of psoriatic arthritis. All-Russian register data]. Terapevticheskii arkhiv 94 (5) (2022)
Evgeniy Nasonov
[Role of interleukin-1 in human diseases: pharmacotherapy prospects: A review]. Terapevticheskii arkhiv 94 (8) (2022)
E A Galushko, A V Gordeev, E V Matyanova, Y A Olyunin, Evgeniy Nasonov
[Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results]. Terapevticheskii arkhiv 94 (5) (2022)
Evgeniy Nasonov
[Janus kinase inhibitors in immunoinflammatory rheumatic diseases]. Terapevticheskii arkhiv 94 (5) (2022)
M S Eliseev, T S Panevin, O V Zhelyabina, Evgeniy Nasonov
[Advantages of the use of metformin in patients with impaired uric acid metabolism]. Terapevticheskii arkhiv 93 (5) (2021)
Elena V Gerasimova, Tatiana V Popkova, Daria A Gerasimova, Svetlana I Glukhova, Evgeniy Nasonov, A M Lila
[Application of cardiovascular risk scales to identify carotid atherosclerosis in patients with rheumatoid arthritis]. Terapevticheskii arkhiv 93 (5) (2021)
A A Abramkin, T A Lisitsyna, D Yu Veltishchev, O F Seravina, O B Kovalevskaya, Svetlana I Glukhova, Evgeniy Nasonov
[Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis]. Terapevticheskii arkhiv 93 (5) (2021)
Y L Korsakova, Tatiana V Korotaeva, E I Loginova, E E Gubar, E A Vasilenko, A A Vasilenko, N A Kuznetsova, I M Patrikeeva, Evgeniy Nasonov
[The relationship between obesity, cardiometabolic disorders and disease activity in psoriatic arthritis patients: data from the Russian register]. Terapevticheskii arkhiv 93 (5) (2021)
Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist, Mariana G Ivanova, Elena Korneva, Diana G Krechikova, Aleksey L Maslyanskiy, Mikhail Samsonov, Rumen Malinov Stoilov, Elena V Zonova, Mark C Genovese
Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study. Annals of the rheumatic diseases (2021)
Evgeniy Nasonov
[2019 Coronavirus disease (COVID-19): contribution of rheumatology]. Terapevticheskii arkhiv 93 (5) (2021)
Evgeniy Nasonov, Tatiana Reshetnyak, Z S Alekberova
[Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity]. Terapevticheskii arkhiv 92 (5) (2020)
T S Panevin, M S Eliseev, Marina V Shestakova, Evgeniy Nasonov
[Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout]. Terapevticheskii arkhiv 92 (5) (2020)
A A Abramkin, T A Lisitsyna, D Yu Veltishchev, O F Seravina, O B Kovalevskaya, Svetlana I Glukhova, Evgeniy Nasonov
[Depression and severity of articular destruction in patients with rheumatoid arthritis]. Terapevticheskii arkhiv 92 (5) (2020)